Red blood cell arginase suppresses Jurkat (T cell) proliferation by depleting arginine

Surgery

Volumn 143, Issue 2, 2008, Pages 286-291

  Bernard, Andrew ^a   Kasten, Michael ^a   Meier, Cindy ^a   Manning, Erin ^a   Freeman, Stephanie ^a   Adams, Will ^a   Chang, Phillip ^a   Boulanger, Bernard ^a   Kearney, Paul ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGINASE; ARGININE; ORNITHINE;

ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LIQUID CHROMATOGRAPHY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ABO BLOOD-GROUP SYSTEM; ARGINASE; ARGININE; CELL DIVISION; CELL LINE, TUMOR; ERYTHROCYTES; HUMANS; JURKAT CELLS; KINETICS; ORNITHINE;

EID: 38649142448     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.07.037     Document Type: Article

References (24)

1. Silliman C., Moore E., Johnson J., et al. Transfusion of the injured patient-Proceed with caution. Shock 21 (2004) 291-299
2. Kuriyan M., and Carson J.L. Anemia and clinical outcomes. Anesthesiol Clin North Am 23 (2005) 315-325
3. Opelz G., Sengar D.P., Mickey M.R., et al. Effect of blood transfusion on subsequent kidney transplants. Transplant Proc 5 (1973) 253-259
4. Palmieri T.L., Caruso D.M., Foster K.N., et al. Effect of blood transfusion on outcome after major burn injury: A multicenter study. Crit Care Med 34 (2006) 1602-1607
5. Amato A., and Pescatori M. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 25 1 (2006) CD005033
6. Vamvakas E.C., and Blajchman M.A. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?. Blood 97 (2002) 1180-1195
7. Kim P.S., Iyer R.K., Lu K.V., et al. Expression of the liver form of arginase in erythrocytes. Mol Gen Metab 76 (2002) 100-110
8. Prins H.A., Houdijk A.P., Nijvedlt R.J., et al. Arginase release from red blood cells: possible link in transfusion induced immune suppression. Shock 16 (2001) 113-115
9. Rodriguez P.C., Quiceno D.G., Zabaleta J., et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 64 (2004) 5839-5849
10. Bronte V., and Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 5 (2005) 641-654
11. Ochoa J.B., Bernard A.C., O'Brien W.E., et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 233 (2001) 393-399
12. Schulz-Burton M.D., Meier C., Freeman S., et al. Peripheral monocyte arginase over-expression in human systemic inflammatory response syndrome (SIRS). JACS 201 (2005) S29
13. Bernard AC, Meier CF, Lopez N, et al. Transfusion-associated arginine depletion is mediated by packed red blood cell (PRBC) arginase. J Trauma, in press.
14. Daly J.M., Lieberman M.D., Goldfine J., et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 112 (1992) 56-67
15. Alexander J.W., Ogle C.K., and Nelson J.L. Diets and infection: components and consequences. World J Surg 22 (1998) 209-212
16. Kashiwakura J., Yokoi H., Saito H., et al. T Cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells. J Immunol 173 (2004) 5247-5257
17. Napolitano L.M., and Corwin H.L. Efficacy of red blood cell transfusion in the critically ill. Crit Care Clin 20 (2004) 255-268
18. Hebert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Eng J Med 340 (1999) 409-417
19. Shorr A.F., Duh M.S., Kelly K.M., et al. Red blood cell transfusion and ventilator-associated pneumonia: A potential link?. Crit Care Med 32 (2004) 666-674
20. Titlestad I.L., Ebbesen L.S., Ainsworth A.P., et al. Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications. Results of a double-blinded, randomized study. Int J Colorectal Dis 16 (2001) 147-153
21. van de Waterling L.M., Brand A., Houbiers J.G., et al. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 88 (2001) 267-272
22. Baron J., Maximilien G., Bertrand M., et al. The effect of universal leukodepletion of packed red blood cells on postoperative infections in high-risk patients undergoing abdominal aortic surgery. Anesth Analg 94 (2002) 529-537
23. McLellan S.A., Walsh T.S., and McClelland D.B. Should we demand fresh red blood cells for perioperative and critically ill patients?. Brit J Anaes (2002) 539-540
24. Makarenkova V.P., Bansal V., Matta B.M., et al. CD11b+/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress. J Immunol 176 (2006) 2085-2094